Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Condition: Carcinoma, Pancreatic DuctalIntervention: Drug: Parvovirus H-1 (H-1PV)Sponsor: Oryx GmbH & Co. KGRecruiting - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Pancreas | Pancreatic Cancer | Parvovirus | Research